May 13th, 2011
ProPublica Takes Aim at SCAI
Now it’s SCAI’s turn. Following its investigation of the Heart Rhythm Society’s ties to industry last week, ProPublica has now focused its attention on the Society for Cardiac Angiography and Interventions (SCAI). In the latest installment of ProPublica’s Dollars for Doctors series, Charles Ornstein writes that SCAI “received 57 percent of its revenues in 2009 from medical device and pharmaceutical makers, according to financial information on the group’s website.” SCAI’s biggest funders are the large stent makers, he reports.
“I don’t think industry is driving the delivery of health care,” Larry Dean, the immediate past-president of SCAI told ProPublica. “The companies that make stents don’t drive it either.”